Factors | Oral Medications | Intracavernosal Injections | Vacuum Pumps | |||||||
---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | ||
Time post-treatment: | 3 months | 2.48 | 1.88–3.27 | < 0.001 | 0.19 | 0.09–0.40 | < 0.001 | 0.42 | 0.23–0.78 | 0.006 |
6 months | 2.10 | 1.63–2.27 | < 0.001 | 0.84 | 0.49–1.44 | 0.530 | 1.35 | 0.80–2.27 | 0.260 | |
12 months | 1.00 | reference | - | 1.00 | reference | - | 1.00 | reference | - | |
2 years | 0.59 | 0.39–0.87 | 0.008 | 1.94 | 1.00–3.77 | 0.051 | 0.38 | 0.12–1.22 | 0.104 | |
5 + years | 0.21 | 0.15–0.30 | < 0.001 | 0.76 | 0.40–1.42 | 0.386 | 0.16 | 0.06–0.42 | < 0.001 | |
Age at diagnosis: | < 60 years | 1.00 | reference | - | 1.00 | reference | - | 1.00 | reference | - |
60–69 years | 0.36 | 0.24–0.54 | < 0.001 | 0.57 | 0.28–1.16 | 0.122 | 0.45 | 0.19–1.04 | 0.062 | |
70–79 years | 0.08 | 0.05–0.13 | < 0.001 | 0.23 | 0.09–0.58 | 0.002 | 0.07 | 0.02–0.26 | < 0.001 | |
≥ 80 years | 0.02 | 0.00–0.05 | < 0.001 | 0.04 | 0.00–1.03 | 0.052 | ||||
Treatment received before completing PROMS (yes v no): | Radical prostatectomy | 4.33 | 2.92–6.42 | < 0.001 | 13.8 | 3.81–49.7 | < 0.001 | 18.0 | 6.55–49.2 | < 0.001 |
Radiation therapy | 0.49 | 0.32–0.73 | 0.001 | 0.95 | 0.42–2.15 | 0.897 | 0.13 | 0.03–0.54 | 0.005 | |
Hormone therapy | 0.26 | 0.12–0.58 | 0.001 | 0.75 | 0.18–3.13 | 0.691 | 0.71 | 0.08–6.58 | 0.765 | |
Observation* | 0.69 | 0.43–1.11 | 0.125 | 0.74 | 0.25–2.22 | 0.590 | 0.45 | 0.10–2.11 | 0.312 | |
PSA at diagnosis: | <4 ng/mL | 1.00 | reference | - | 1.00 | reference | - | 1.00 | reference | - |
4–10 ng/mL | 0.58 | 0.36–0.92 | 0.020 | 0.88 | 0.33–2.32 | 0.797 | 0.82 | 0.26–2.58 | 0.732 | |
> 10 ng/mL | 0.28 | 0.16–0.49 | < 0.001 | 1.07 | 0.36–3.24 | 0.9 | 1.02 | 0.27–3.78 | 0.978 | |
Gleason score: | ≤ 6 | 1.00 | reference | - | 1.00 | reference | - | 1.00 | reference | - |
7 | 1.48 | 0.96–2.28 | 0.076 | 2.35 | 0.94–5.89 | 0.067 | 2.66 | 0.58–12.2 | 0.209 | |
8–10 | 0.62 | 0.35–1.10 | 0.103 | 1.81 | 0.57–5.72 | 0.312 | 1.58 | 0.23–10.8 | 0.640 | |
Geographic location: | Major city/outer urban | 1.00 | reference | - | 1.00 | reference | - | 1.00 | reference | - |
Outer Regional | 0.96 | 0.58–1.58 | 0.869 | 2.78 | 1.05–7.35 | 0.040 | 2.01 | 0.70–5.83 | 0.196 | |
Remote/Very remote | 1.33 | 0.66–2.68 | 0.426 | 2.56 | 0.66–9.90 | 0.172 | ||||
Socioeconomic Status (quintiles): | Most disadvantaged Q1 | 1.00 | reference | - | 1.00 | reference | - | 1.00 | reference | - |
Q2 | 1.45 | 0.87–2.41 | 0.152 | 0.98 | 0.33–2.92 | 0.969 | 1.78 | 0.48–6.64 | 0.392 | |
Q3 | 1.30 | 0.76–2.23 | 0.345 | 0.73 | 0.21–2.51 | 0.620 | 0.95 | 0.21–4.33 | 0.945 | |
Q4 | 1.68 | 1.01–2.80 | 0.047 | 3.06 | 1.08–8.68 | 0.035 | 1.58 | 0.41–6.02 | 0.504 | |
Most advantaged Q5 | 2.41 | 1.47–3.93 | < 0.001 | 2.39 | 0.84–6.81 | 0.104 | 1.11 | 0.29–4.30 | 0.877 | |
Continence score: | per 10 pt score increase | 1.07 | 1.01–1.13 | 0.020 | 1.03 | 0.92–1.15 | 0.642 | 0.99 | 0.87–1.13 | 0.933 |
Body mass index: | Healthy | 1.00 | reference | - | 1.00 | reference | - | 1.00 | reference | - |
Overweight | 1.52 | 1.07–2.15 | 0.018 | 0.83 | 0.41–1.68 | 0.613 | 1.33 | 0.51–3.44 | 0.558 | |
Obese | 0.70 | 0.47–1.05 | 0.084 | 0.85 | 0.43–2.07 | 0.889 | 0.95 | 0.32–2.85 | 0.929 | |
Smoking status: | Never smoked | 1.00 | - | - | 1.00 | reference | - | 1.00 | reference | - |
Past smoker | 0.77 | 0.58–1.01 | 0.061 | 0.89 | 0.50–1.57 | 0.684 | 0.74 | 0.36–1.52 | 0.415 | |
Current smoker | 0.68 | 0.38–1.21 | 0.191 | 1.89 | 0.68–5.26 | 0.224 | 0.36 | 0.06–2.10 | 0.256 | |
Depression symptoms | Small-large v none/very small problem | 0.48 | 0.27–0.84 | 0.011 | 0.52 | 0.15–1.76 | 0.290 | 2.00 | 0.52–7.68 | 0.313 |